Skip to main content
2025 CRT Conference Main banner
Back

Gregory P. Fontana, MD

Director, CardioVascular Institute
Hospital Corporation of America
Thousand oaks, United States

Dr. Fontana is an international leader in cardiothoracic surgery, whose primary professional focus has been on less invasive approaches for the
treatment of structural heart disease. He has been a pioneer and principal investigator for several minimally invasive approaches involving transcatheter valve therapies and minimally invasive surgical procedures for congenital and acquired heart disease. Among many others, he has been a principal investigator in the Partner Trial, the CoreValve Pivotal trial, the Medtronic Low-Risk TAVR Trial, and the Perceval trial of sutureless aortic valves, He is the national principal investigator for the St. Jude/Abbott Transcatheter Portico Valve IDE Pivotal trial. He is also a widely published researcher and author with over 150 academic citations. He currently serves as the National Director for Cardiovascular Research for Hospital Corporation of America.

Disclosure information not submitted.

Presentation(s):

Email Gregory